Where the U.S. stands in its battle against COVID-19
New subvariants, vaccines for kids, and everything else to know about COVID-19 today
![A mask.](https://cdn.mos.cms.futurecdn.net/hP6ARqMLsxPGyCQQCn4Mtn-415-80.jpg)
The World Health Organization declared COVID-19 a global pandemic two years ago, and now, epidemiologists and public health experts are ready to talk about the virus becoming endemic. Across the United States, cities and schools continue to relax their COVID-19 mask mandates, while scientists are keeping an eye on the BA.2 subvariant that is accounting for more and more infections. When it comes to COVID, there's a lot going on — here's what you need to know:
What is the BA.2 subvariant?
BA.2 is a subvariant of Omicron, and is highly transmissible — it's estimated to be between 30 and 60 percent more contagious than Omicron. As of Tuesday, BA.2 accounted for almost 35 percent of COVID-19 cases in the United States, the Centers for Disease Control and Prevention said, up from 23 percent a week earlier. It's most prevalent in Massachusetts, New Hampshire, Connecticut, and Maine, having been detected in more than 50 percent of cases in those states.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
![https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg](https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516-320-80.jpg)
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Should Americans start worrying about BA.2?
Even though it's more transmissible, many experts say they don't envision BA.2 leading to a spike in hospitalizations and deaths in the United States. On Thursday, the daily average number of new cases in the U.S. was 30,387, down 15 percent from two weeks earlier. Dr. John Brooks, a medical epidemiologist and chief medical officer for the CDC's COVID-19 response, told NBC News new data suggests BA.2 is "going to keep growing." However, because Omicron swept across the country during the winter, those who were infected during the surge likely have higher immunity from BA.2 and other subvariants. "Prior infection with the original Omicron appears to confer protection," Brooks said. "Not necessarily against infection but definitely against severe disease and death." Vaccination also continues to offer defense against the virus.
What should people do to prepare for a potential surge?
Get vaccinated and boosted, if eligible. "We have fair warning," Brooks told NBC News. "We are swimming in vaccine in this country. You can get it for free. Go do it." People should also continue to wear masks while inside public spaces, even if mandates have been dropped, and get tested before and after attending events, he recommended.
Are we getting closer to a COVID-19 vaccine for kids 5 and under?
On Wednesday, Moderna announced that data from a recent trial shows its COVID-19 vaccine generated a strong immune response in kids between 6 months and 6 years old. About 6,900 children participated in the trial, and received a quarter of the dose given to adults. Most of the side effects reported were "mild or moderate," Moderna said, with zero cases of the rare heart condition myocarditis. Moderna said it will submit the data to the Food and Drug Administration within the next few weeks, and intends to seek emergency use authorization for the vaccine in kids 6 and under. The company also said it is getting ready to evaluate booster doses for all children.
When might COVID-19 enter its endemic stage?
When a disease is "endemic," it's still present in the population and causing individual cases, but can be managed better and is more predictable than in the pandemic stage. One example is influenza — most strains are endemic because public health experts can reasonably predict when flu season will start and end, and know precautions people can take (vaccination, wearing masks) in order to go about their lives as normal as possible.
Everyone wants to reach the endemic stage, Charlotte Baker, an epidemiology professor at Virginia Tech, told NPR, but "the problem hanging over all of us is what happens if a new variant should occur." If a new variant emerges that is worse than previous ones, the endemic stage will be pushed back.
The goal is to be at "a very low endemic disease pattern," Dr. John Swartzberg, an epidemiologist at UC Berkeley, explained to ABC 10. "That's critical. A really high pattern is not going to be good for anybody." Vaccination will still be key, and even in the endemic stage, those who are unvaccinated or have underlying risk factors could still wind up in the hospital. It's also important to note that malaria, which caused an estimated 627,000 deaths in 2020, is also considered endemic in some countries.
Could COVID-19 ever be eradicated?
That's unlikely. COVID-19 has been found in animals, like deer and hamsters, and "once you have a disease with an animal reservoir, it's very hard to eradicate," Dr. Isaac Weisfuse, an epidemiologist and adjunct professor at Cornell University, told NPR. Case in point: in Hong Kong, it's believed that at least three COVID-19 cases can be linked to hamsters at a pet store. While international health authorities say the risk of transmission is low, it is always possible that once a disease is in an animal, it can make its way to humans, Weisfuse said.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
10 recent scientific breakthroughs
In Depth From cell reparation to monkey communication
By Devika Rao, The Week US Published
-
TV to watch in September, from 'Agatha All Along' to 'The Penguin'
The Week Recommends A 'WandaVision' spinoff, a DC Comics villain's starring turn and a silly Netflix original
By Anya Jaremko-Greenwold, The Week US Published
-
Pope urges climate action, unity at Jakarta mosque
Speed Read The pope and the mosque's top cleric signed a joint declaration encouraging religious tolerance and climate change action
By Peter Weber, The Week US Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Published
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published
-
Should masks be here to stay?
Talking Points New York Governor Kathy Hochul proposed a mask ban. Here's why she wants one — and why it may not make sense.
By Anya Jaremko-Greenwold, The Week US Published
-
Covid might be to blame for an uptick in rare cancers
The explainer The virus may be making us more susceptible to certain cancers
By Devika Rao, The Week US Published
-
Long Covid and chronic pain: is it all in the mind?
The Explainer 'Retraining the brain' could offer a solution for some long Covid sufferers
By The Week UK Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published